Studies have shown that AD patients exhibit elevated levels of active caspase-3 (cleaved caspase-3, Clv.C-3), particularly enriched in the postsynaptic density (PSD), indicating its critical role in synaptic dysfunction and degeneration [31]. This evidence concerns the gene CASP3 and Alzheimer disease.